Source: Korea Biomedical Review

LG Chem: Merck Korea and LG Chem to co-promote type-2 diabetes drugs in Korea

Merck Biopharma Korea said Wednesday that it signed a partnership agreement with LG Chem to distribute its Glucophage family of type 2 diabetes treatments in Korea.The portfolio includes Glucophage IR (immediate release), Glucophage XR (extended release), both metformin hydrochloride tablets, and Gl

Read full article »
Annual Revenue
$10-50B
Employees
10-50K
Hak Cheol Shin's photo - CEO of LG Chem

CEO

Hak Cheol Shin

CEO Approval Rating

70/100

Read more